NEI
DGX icon

Northwest & Ethical Investments’s Quest Diagnostics DGX Stock Holding History

Northwest & Ethical Investments’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.82M Sell
8,571
-6,790
-44% -$1.33M 0.04% 226
2026
Q1 		$3.01M Buy
15,361
+8,812
+135% +$1.71M 0.07% 223
2025
Q4 		$1.14M Buy
6,549
+411
+7% +$74.8K 0.03% 301
2025
Q3 		$1.17M Hold
6,138
– – 0.03% 319
2025
Q2 		$1.1M Buy
+6,138
New +$1.07M 0.03% 321
2023
Q2 		– Sell
-6,078
Closed -$860K – 392
2023
Q1 		$860K Hold
6,078
– – 0.03% 316
2022
Q4 		$951K Buy
6,078
+487
+9% +$70K 0.03% 304
2022
Q3 		$686K Sell
5,591
-153
-3% -$20.1K 0.03% 328
2022
Q2 		$764K Hold
5,744
– – 0.03% 324
2022
Q1 		$786K Sell
5,744
-1,424
-20% -$198K 0.03% 322
2021
Q4 		$1.24M Buy
7,168
+4,145
+137% +$631K 0.04% 279
2021
Q3 		$439K Sell
3,023
-6,271
-67% -$918K 0.01% 342
2021
Q2 		$1.23M Sell
9,294
-9,074
-49% -$1.19M 0.04% 285
2021
Q1 		$2.36M Buy
18,368
+4,329
+31% +$533K 0.08% 248
2020
Q4 		$1.67M Sell
14,039
-973
-6% -$119K 0.06% 275
2020
Q3 		$1.72M Sell
15,012
-5,963
-28% -$705K 0.08% 254
2020
Q2 		$2.39M Buy
20,975
+6,439
+44% +$683K 0.11% 213
2020
Q1 		$1.17M Buy
+14,536
New +$1.5M 0.07% 274
2019
Q2 		– Sell
-24,520
Closed -$2.2M – 365
2019
Q1 		$2.2M Sell
24,520
-480
-2% -$41.6K 0.12% 233
2018
Q4 		$2.08M Buy
25,000
+7,100
+40% +$666K 0.12% 222
2018
Q3 		$1.93M Hold
17,900
– – 0.12% 228
2018
Q2 		$1.97M Sell
17,900
-600
-3% -$62.5K 0.13% 222
2018
Q1 		$1.86M Buy
18,500
+8,200
+80% +$840K 0.12% 225
2017
Q4 		$1.01M Sell
10,300
-4,600
-31% -$436K 0.07% 281
2017
Q3 		$1.4M Sell
14,900
-4,000
-21% -$425K 0.09% 253
2017
Q2 		$2.1M Sell
18,900
-600
-3% -$63.4K 0.14% 186
2017
Q1 		$1.91M Buy
+19,500
New +$1.86M 0.13% 200
2016
Q3 		– Sell
-57,945
Closed -$4.72M – 327
2016
Q2 		$4.72M Sell
57,945
-2,196
-4% -$167K 0.36% 71
2016
Q1 		$4.3M Sell
60,141
-5,644
-9% -$379K 0.29% 94
2015
Q4 		$4.68M Sell
65,785
-2,557
-4% -$172K 0.34% 85
2015
Q3 		$4.2M Buy
68,342
+2,959
+5% +$207K 0.32% 87
2015
Q2 		$4.74M Sell
65,383
-4,813
-7% -$355K 0.31% 86
2015
Q1 		$5.39M Sell
70,196
-5,881
-8% -$421K 0.38% 67
2014
Q4 		$5.1M Sell
76,077
-6,183
-8% -$390K 0.34% 71
2014
Q3 		$4.99M Buy
82,260
+11,737
+17% +$723K 0.33% 73
2014
Q2 		$4.14M Buy
70,523
+31,769
+82% +$1.86M 0.26% 97
2014
Q1 		$2.24M Buy
+38,754
New +$2.08M 0.15% 155

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Northwest & Ethical Investments's DGX Position: Q2 2026 in Review

Northwest & Ethical Investments reduced its Quest Diagnostics (DGX) stake by 44% in Q2 2026, selling an estimated $1.33M and leaving 8,571 shares worth $1.82M. The position accounts for 0.04% of the portfolio, ranked #226.

Northwest & Ethical Investments first reported a position in DGX in Q1 2014 and has held it in 37 quarters since. The position peaked at $5.39M in Q1 2015. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Northwest & Ethical Investments held 8,571 shares of Quest Diagnostics worth $1.82M as of Q2 2026.
  • Northwest & Ethical Investments sold 6,790 Quest Diagnostics shares in Q2 2026, an estimated $1.33M.
  • Quest Diagnostics made up 0.04% of Northwest & Ethical Investments's portfolio in Q2 2026, its #226 holding.
  • Northwest & Ethical Investments first reported a position in Quest Diagnostics in Q1 2014 and has held it in 37 quarters since.
  • Northwest & Ethical Investments's Quest Diagnostics position peaked at $5.39M in Q1 2015.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Northwest & Ethical Investments's 13F filing for Q2 2026, filed 13 Aug 2026.